New research reveals that tirzepatide and semaglutide both offer strong, early heart-protective effects. A major new investigation from Mass General Brigham has directly compared the heart-protective effects of two popular diabetes medications, tirzepatide and semaglutide. The findings reveal that both drugs significantly lower the risk of heart attack, stroke, and death from any cause. The […]
Source link